Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SNCY
|
David M Davis
President & CFO |
SELL
Open market or private sale
|
Direct | 59,380 Reduced 64.8% |
$1,004,115
$16.91 p/Share
|
Jan 21
2025 |
|
RNA
|
Michael F Mac Lean
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,287 Reduced 3.05% |
$93,975
$28.59 p/Share
|
Jan 21
2025 |
|
RNA
|
Arthur A Levin
Director |
SELL
Open market or private sale
|
Direct | 1,872 Reduced 12.62% |
$53,539
$28.6 p/Share
|
Jan 21
2025 |
|
RNA
|
Sarah Boyce
President and CEO |
SELL
Open market or private sale
|
Direct | 10,397 Reduced 2.99% |
$297,250
$28.59 p/Share
|
Jan 21
2025 |
|
RNA
|
W. Michael Flanagan
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 5,672 Reduced 5.81% |
$162,219
$28.6 p/Share
|
Jan 21
2025 |
|
RNA
|
Teresa Mc Carthy
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,959 Reduced 2.74% |
$84,627
$28.6 p/Share
|
Jan 21
2025 |
|
TTD
|
Jeffrey Terry Green
President and CEO |
SELL
Open market or private sale
|
Indirect | 512,953 Reduced 0.0% |
$63,996,016
$124.76 p/Share
|
Jan 21
2025 |
|
RNA
|
Steven George Hughes
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,947 Reduced 4.57% |
$112,884
$28.6 p/Share
|
Jan 21
2025 |
|
RNA
|
Kathleen P. Gallagher
Chief Program Officer |
SELL
Open market or private sale
|
Direct | 3,782 Reduced 6.31% |
$108,127
$28.59 p/Share
|
Jan 21
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 12,901 Reduced 0.12% |
$146,426
$11.35 p/Share
|
Jan 21
2025 |
|
BPMC
|
Kate Haviland
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 1,446 Reduced 0.96% |
$159,407
$110.24 p/Share
|
Jan 21
2025 |
|
BPMC
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct | 15,161 Reduced 9.05% |
$1,665,890
$109.88 p/Share
|
Jan 21
2025 |
|
BPMC
|
Christina Rossi
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 2,274 Reduced 3.28% |
$251,026
$110.39 p/Share
|
Jan 21
2025 |
|
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 5,117 Reduced 0.0% |
$53,165
$10.39 p/Share
|
Jan 21
2025 |
|
SOFI
|
Kelli Keough
EVP, GBUL, SIPS |
SELL
Open market or private sale
|
Direct | 8,914 Reduced 4.75% |
$156,708
$17.58 p/Share
|
Jan 21
2025 |
|
ETNB
|
Charles Mc Wherter |
BUY
Open market or private purchase
|
Direct | 5,000 Added 25.0% |
$32,750
$6.55 p/Share
|
Jan 21
2025 |
|
A
|
Padraig Mcdonnell
President and CEO |
SELL
Open market or private sale
|
Direct | 1,911 Reduced 4.6% |
$286,650
$150.0 p/Share
|
Jan 21
2025 |
|
RPD
|
Corey E. Thomas
CEO |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 18.82% |
$3,938,000
$39.38 p/Share
|
Jan 21
2025 |
|
ANET
|
Yvonne Wassenaar
Director |
SELL
Open market or private sale
|
Direct | 168 Reduced 1.24% |
$20,361
$121.2 p/Share
|
Jan 21
2025 |
|
RLAY
|
Sanjiv Patel
President and CEO |
SELL
Open market or private sale
|
Indirect | 125,000 Reduced 0.0% |
$565,000
$4.52 p/Share
|
Jan 21
2025 |
|
CRCT
|
Arora Ashish
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 21,250 Reduced 0.57% |
$122,187
$5.75 p/Share
|
Jan 21
2025 |
|
SGA
|
Edward K. Christian Trust |
SELL
Open market or private sale
|
Direct | 2,326 Reduced 0.24% |
$28,144
$12.1 p/Share
|
Jan 21
2025 |
|
META
|
Javier Olivan
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 413 Reduced 2.47% |
$255,234
$618.0 p/Share
|
Jan 21
2025 |
|
ATEC
|
Patrick Miles
CEO |
SELL
Open market or private sale
|
Direct | 6,687 Reduced 0.12% |
$80,244
$12.0 p/Share
|
Jan 21
2025 |
|
BLK
|
J. Richard Kushel
Senior Managing Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 12.75% |
$10,100,000
$1010.0 p/Share
|
Jan 21
2025 |
|
META
|
Jennifer Newstead
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 905 Reduced 2.91% |
$559,290
$618.0 p/Share
|
Jan 21
2025 |
|
SNOW
|
Benoit Dageville
President of Products |
SELL
Open market or private sale
|
Direct | 18,750 Reduced 28.21% |
$3,281,250
$175.0 p/Share
|
Jan 21
2025 |
|
SNOW
|
Frank Slootman
Director |
SELL
Open market or private sale
|
Direct | 72,753 Reduced 27.14% |
$12,785,612
$175.74 p/Share
|
Jan 21
2025 |
|
WSM
|
Laura Alber
PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 4.55% |
$9,386,100
$208.58 p/Share
|
Jan 21
2025 |
|
AVMR
|
Barry F Cohen
COO - Americas |
BUY
Open market or private purchase
|
Direct | 118 Added 0.0% |
$1,019
$8.64 p/Share
|
Jan 21
2025 |
|
AAOI
|
Stefan J. Murry
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 2,298 Reduced 1.08% |
$80,820
$35.17 p/Share
|
Jan 21
2025 |
|
TBPH
|
Rhonda Farnum
SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 1.28% |
$36,000
$9.0 p/Share
|
Jan 21
2025 |
|
LOOP
|
Laurence G. Sellyn |
BUY
Open market or private purchase
|
Direct | 29,937 Added 13.14% |
$31,433
$1.05 p/Share
|
Jan 21
2025 |
|
DSAC
|
Gerald Yao
CSO and Director |
SELL
Open market or private sale
|
Indirect | 2,750 Reduced 0.0% |
$4,125
$1.5 p/Share
|
Jan 21
2025 |
|
SHRG
|
Heng Fai Ambrose Chan
Director |
BUY
Open market or private purchase
|
Direct | 7,701 Added 50.0% |
$13,245
$1.72 p/Share
|
Jan 21
2025 |
|
ZIP
|
Ryan T. Sakamoto
EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 1,925 Reduced 1.71% |
$13,417
$6.97 p/Share
|
Jan 21
2025 |
|
PCOR
|
Benjamin C Singer
Chief Legal Officer; Secretary |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 1.77% |
$117,000
$78.0 p/Share
|
Jan 21
2025 |
|
ABOS
|
Russell Barton
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,914 Reduced 2.1% |
$4,691
$1.61 p/Share
|
Jan 21
2025 |
|
HNRA
|
Pogo Royalty, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,071,897 Reduced 68.19% |
$1,704,316
$1.59 p/Share
|
Jan 21
2025 |
|
ABOS
|
Derek M Meisner
Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct | 3,418 Reduced 2.08% |
$5,434
$1.59 p/Share
|
Jan 21
2025 |
|
ABOS
|
Daniel Joseph O Connell
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 12,619 Reduced 1.86% |
$20,064
$1.59 p/Share
|
Jan 21
2025 |
|
OKTA
|
Jacques Frederic Kerrest
Director |
SELL
Open market or private sale
|
Direct | 3,306 Reduced 100.0% |
$293,936
$88.91 p/Share
|
Jan 21
2025 |
|
OKTA
|
Brett Tighe
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.25% |
$445,550
$89.11 p/Share
|
Jan 21
2025 |
|
ALHC
|
Hakan Kardes
Chief Experience Officer |
SELL
Open market or private sale
|
Direct | 10,500 Reduced 3.28% |
$157,395
$14.99 p/Share
|
Jan 21
2025 |
|
ULY
|
Ben Volkow |
SELL
Open market or private sale
|
Direct | 8,800 Reduced 2.24% |
$4,312
$0.49 p/Share
|
Jan 21
2025 |
|
ABOS
|
Eric Siemers
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,219 Reduced 1.86% |
$5,118
$1.59 p/Share
|
Jan 21
2025 |
|
LQDA
|
Rajeev Saggar
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,445 Reduced 0.9% |
$31,785
$13.0 p/Share
|
Jan 21
2025 |
|
SVV
|
Richard A. Medway
General Counsel |
SELL
Open market or private sale
|
Direct | 4,800 Reduced 100.0% |
$55,104
$11.48 p/Share
|
Jan 21
2025 |
|
RIVN
|
Robert J Scaringe
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 35,713 Reduced 3.97% |
$491,410
$13.76 p/Share
|
Jan 21
2025 |
|
ZVIA
|
Lorna R. Simms
SVP, GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct | 3,979 Reduced 1.71% |
$18,621
$4.68 p/Share
|
Jan 21
2025 |